Pfizer (PFE) Stock Rallies on November 21, 2025 as Investors Focus on FDA Win, Obesity Pivot and 7% Dividend Yield
New York – November 21, 2025 Pfizer (NYSE: PFE) finished Friday’s session on a strong note, with the stock climbing as investors digested a fresh U.S. FDA approval in bladder cancer, progress in obesity drugs, a multi‑billion‑dollar bond sale and